血管醇异构酶和氧化还原系统在血小板功能和血栓形成中的最新进展
1Department of Cardiovascular Sciences, Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Journal of thrombosis and haemostasis : JTH
|March 22, 2024
概括
血管蛋白二硫化异构酶 (PDIs) 调节血小板功能和血栓形成. 特定的PDI如ERp46和PDI促进聚合,而跨膜蛋白1抑制它,影响血液静止和临床结果.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 血管蛋白二硫化异构酶 (PDIs) 在血小板功能和血栓形成中起着至关重要的作用.
- 几种PDI表现出原血栓性 (PDI,ERp57,ERp72,ERp46) 或抗血栓性 (跨膜蛋白1) 活动.
- 血小板中的第六个PDIERp5的功能仍然模糊不清,可能是前血栓性或抗血栓性.
研究的目的:
- 阐明血管PDI在血小板功能和血栓形成中的机制.
- 研究ERp46,PDI和跨膜蛋白1在血小板聚合和整合素激活中的特定作用.
- 了解PDI及其基质在血液静止和血栓形成中的氧化还原调节.
主要方法:
- 酶活性测定用于确定PDI在血小板聚合中的功能.
- 集成激活研究侧重于αIIbβ3和αMβ2.
- 在各种条件下分析PDI域的氧化还原状态.
主要成果:
- 经ERp46催化的αIIbβ3的二硫化物裂变在PDI介导的事件之前,增强了血小板聚合.
- 跨膜蛋白1抑制αIIbβ3激活,抵消ERp46的原血栓作用.
- 氧化PDI促进血小板聚合,其a'域被构成性氧化,而a域在压力下被氧化;减少PDI抑制中性粒细胞整合素αMβ2.
- 细胞内血小板PDI与Nox1合作,增加了血栓素A2的产生.
结论:
- 血管PDI形成了对血液静止和血栓形成至关重要的氧化还原网络.
- 了解PDI基质和功能,可以了解静血和血栓机制.
- 了解PDI及其向的二硫化物键对治疗血栓性疾病具有重大临床意义.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Formation of the Platelet Plug
6.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.1K
Clot Retraction and Fibrinolysis
5.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.8K
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885


